Followers | 194 |
Posts | 11500 |
Boards Moderated | 2 |
Alias Born | 06/20/2022 |
Wednesday, March 22, 2023 12:32:03 PM
Recent ZURA News
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 08:57:03 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/11/2024 04:15:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:22:58 PM
- Zura Bio to Present at Three Upcoming Investor Conferences in September • Business Wire • 09/03/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:01:20 PM
- Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights • Business Wire • 08/13/2024 01:21:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/12/2024 08:46:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:42:26 PM
- Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants • Business Wire • 08/12/2024 08:05:00 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 08/09/2024 09:26:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/09/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:33:38 PM
- Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants • Business Wire • 08/09/2024 08:05:00 PM
- Zura Bio Commences Warrant Exchange Offer and Consent Solicitation • Business Wire • 07/12/2024 10:10:00 AM
- Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024 • Business Wire • 06/14/2024 10:00:00 AM
- Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology • Business Wire • 06/06/2024 10:00:00 AM
- Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024 • Business Wire • 06/03/2024 10:00:00 AM
- Zura Bio Announces Participation in June Investor Conferences • Business Wire • 05/29/2024 10:00:00 AM
- Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights • Business Wire • 05/09/2024 10:00:00 AM
- Zura Bio Announces Oversubscribed $112.5 Million Private Placement • Business Wire • 04/18/2024 01:22:00 PM
- Zura Bio Announces Robert Lisicki as CEO and Director • Business Wire • 04/08/2024 10:00:00 AM
- Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer • Business Wire • 03/28/2024 10:00:00 AM
- Zura Bio Announces Participation at March Conferences • Business Wire • 03/04/2024 11:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM